Modeling Doxorubicin-Induced Cardiomyopathy With Fibrotic Myocardial Damage in Wistar Rats.
Ekaterina PodyachevaTatiana ShmakovaEkaterina KushnarevaAnatoliya OnopchenkoMikhail MartynovDaria AndreevaRoman ToropovYuri CheburkinKsenia LevchukAlexandra GoldaevaYana G ToropovaPublished in: Cardiology research (2022)
We assume that cumulative dose of 10 mg/kg with a frequency of administration of six times in 2 days can be used to study the mechanisms of anthracycline cardiomyopathy development.